南方医科大学学报 ›› 2021, Vol. 41 ›› Issue (3): 399-405.doi: 10.12122/j.issn.1673-4254.2021.03.12

• • 上一篇    下一篇

柴胡桂枝汤通过sirt1-p53信号通路产生抗抑郁作用

葛鑫宇,郭 芳,范 俊,陈宝田,于 林,任 静,李纪强,卢成林,莫嘉文,李树基,袁乐欣,胡号应,刘 赟, 周 晓,崔 娟,朱志敏,曹 雄   

  • 出版日期:2021-03-20 发布日期:2021-04-04

Chaihu Guizhi decoction produces antidepressant-like effects via sirt1-p53 signaling pathway

  • Online:2021-03-20 Published:2021-04-04

摘要:

目的 探讨柴胡桂枝汤的抗抑郁效应和作用机制。方法 设两组成年雄性C57BL/6J小鼠:柴胡桂枝汤组(CGD,n=12)接受连续7 d的柴胡桂枝汤灌胃给药,药物浓度为17 g·kg-1·d-1;溶剂对照组(Vehicle,n=14)接受连续7 d的药物溶剂灌胃给药。采用强迫游泳实验(FST)、高架十字迷宫实验(EPM)、新环境压抑进食实验(NSF)以及旷场实验(OFT),检测两组小鼠的抑郁样行为、焦虑样行为和运动能力。进一步使用慢性社会挫败应激模型(CSDS)和社会交互实验(SI)明确柴胡桂枝汤在动物抑郁模型中的抗抑郁作用;造模和对照小鼠连续接受柴胡桂枝汤或溶剂7 d灌胃处理,具体分组为:造模鼠+柴胡桂枝汤组(CSDS+CGD,17 g·kg-1·d-1,n=8)、造模鼠+溶剂组(CSDS+vehicle,
n=11)、对照鼠+柴胡桂枝汤组(Con+CGD,17 g·kg-1·d-1,n=8)、对照鼠溶剂组(Con+vehicle,n=6)。此外,采用蛋白质免疫印迹(Western blot)、实时荧光定量聚合酶链反应(qRT-PCR)检测柴胡桂枝汤给药组及溶剂对照组小鼠海马组织中的sirt1、p53、乙酰化p53蛋白水平和海马神经元突触可塑性相关基因synapsin I(Syn1)、Rab4B、SNAP25和Tubulin beta4b的表达。结果 柴胡桂枝汤组小鼠在FST中的不动时间显著性减少(P<0.05);两组动物在EPM、NSF和OFT实验中无显著性差异;在SI行为实验中,CSDS+vehicle组小鼠与其他3组相比,在交互区的停留时间有显著性差异(P<0.05)。与溶剂对照组相比,柴胡桂枝汤组小鼠海马区sirt1蛋白水平上升,乙酰化p53蛋白水平下降(P<0.05),突触可塑性相关蛋白Syn1 mRNA表达上调(P<0.05),Rab(P=0.813),SNAP(P=0.820),Tubb(P=0.864)的mRNA表达没有显著性差异。结论 柴胡桂枝汤在FST和CSDS动物模型中都具有抗抑郁样作用;可能通过sirt1-p53通路及突触可塑性机制发挥其抗抑郁效应。

关键词:

Abstract:

Objective To investigate the mechanism of the antidepressant-like effects of Chaihu Guizhi decoction (CGD). Methods Chaihu Guizhi decoction at the daily dose of 17 g/kg and solvent vehicle were administered by gavage in 12 and 14 male C57BL/6J mice for 7 consecutive days, respectively. Forced swimming test (FST), elevated plus maze (EPM) test, open field test (OFT) and novelty-suppressed feeding test (NSF) were performed to assess the depression- and anxiety-like behaviors and motor ability of the mice. We further used chronic social defeat stress (CSDS) and social interaction test to evaluate the antidepressant-like effects of CGD in comparison with the solvent vehicle. Western blotting and RT-qPCR were performed to detect the expressions of sirt1, p53, acetylated p53, and the neuron plasticity-related genes including synapsin I (Syn1), Rab4B, SNAP25 and tubulin beta4b in the hippocampus of the mice. Results In FST, the immobility time of CGD-treated mice was decreased significantly (P<0.05); no significant differences were found in the performances in EPM, NSF and OFT tests between the two groups. In social interaction test, the mouse models of CSDS treated with CGD showed significantly increased time in the interaction zone (P<0.05). Compared with those in the vehicle group, the CGD-treated mouse models exhibited significantly increased protein level of SIRT1 and decreased p53 acetylation (P<0.05) with up- regulated synapsin I mRNA expression in the hippocampus (P<0.05); no significant difference were found in Rab (P=0.813), SNAP (P=0.820), or Tubb mRNA expressions (P=0.864) between the two groups. Conclusion CGD produces antidepressant-like effects in mice possibly through the sirt1-p53 signaling pathway and synaptic plasticity.

Key words: